Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Millennium identifies key mediator of allergic immune response

Nov. 4, 1999

Shionogi describes wide series of sPLA2 inhibitors

Nov. 3, 1999

Dura begins clinical program on Budesonide Spiros

Oct. 29, 1999

Nortran's intractable cough treatment completes safety trial

Oct. 29, 1999

Dainippon Ink & Chemicals begins clinical testing of allergy drug

Oct. 28, 1999

Schering-Plough files for marketing clearance for desloratadine on two continents

Oct. 27, 1999

Sheffield Pharmaceuticals completes inhaled steroid agreement with Elan

Oct. 26, 1999

Potent new methylprednisolone and betamethasone derivatives show promise for asthma

Oct. 20, 1999

Glaxo Wellcome's Advair Diskus NDA to be reviewed at late November advisory committee meeting

Oct. 19, 1999

Dura and Spiros initiate pivotal clinical program for Beclomethasone Spiros

Oct. 18, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...